Do statins prevent or promote cancer?
作者信息
Goldstein Mark R, Mascitelli Luca, Pezzetta Francesca
出版信息
Curr Oncol. 2008 Apr;15(2):76-7. doi: 10.3747/co.v15i2.235.
Abstract
摘要
相似文献
1
Do statins prevent or promote cancer?
Curr Oncol. 2008 Apr;15(2):76-7. doi: 10.3747/co.v15i2.235.
2
Regulatory T cells: Possible mediators for the anti-inflammatory action of statins.
Pharmacol Res. 2019 Nov;149:104469. doi: 10.1016/j.phrs.2019.104469. Epub 2019 Sep 29.
3
Statins and cancer.
Anticancer Agents Med Chem. 2014 Jun;14(5):706-12. doi: 10.2174/1871520613666131129105035.
4
Effect of statins on breast cancer recurrence and mortality: a review.
Breast Cancer (Dove Med Press). 2017 Dec 1;9:559-565. doi: 10.2147/BCTT.S148080. eCollection 2017.
5
Immunomodulatory effect of statins on Regulatory T Lymphocytes in human colorectal cancer is determined by the stage of disease.
Oncotarget. 2018 Nov 6;9(87):35752-35761. doi: 10.18632/oncotarget.26293.
6
The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer.
Immunobiology. 2018 Feb;223(2):171-177. doi: 10.1016/j.imbio.2017.10.029. Epub 2017 Oct 16.
7
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.
J Am Coll Cardiol. 2013 Dec 3;62(22):2090-9. doi: 10.1016/j.jacc.2013.07.069. Epub 2013 Aug 28.
8
Pharmacological actions of statins: a critical appraisal in the management of cancer.
Pharmacol Rev. 2012 Jan;64(1):102-46. doi: 10.1124/pr.111.004994. Epub 2011 Nov 21.
9
[Immunomodulatory properties of statins and cancer risk].
Recenti Prog Med. 2009 Jan;100(1):33-9.
10
Oxidized Low-Density Lipoprotein (OxLDL)-Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let-7c Is Integral to the Effect.
J Am Heart Assoc. 2016 Sep 20;5(9):e003976. doi: 10.1161/JAHA.116.003976.
引用本文的文献
1
Association between Statin Use and Gastric Cancer: A Nested Case-Control Study Using a National Health Screening Cohort in Korea.
Pharmaceuticals (Basel). 2021 Dec 8;14(12):1283. doi: 10.3390/ph14121283.
2
Association between plasma lipid levels during acute coronary syndrome and long-term malignancy risk. The ABC-4* study on heart disease.
BMC Cardiovasc Disord. 2019 May 20;19(1):119. doi: 10.1186/s12872-019-1092-5.
3
Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin.
Cancer Manag Res. 2018 Jul 13;10:2003-2018. doi: 10.2147/CMAR.S161824. eCollection 2018.
4
Mechanobiology of YAP and TAZ in physiology and disease.
Nat Rev Mol Cell Biol. 2017 Dec;18(12):758-770. doi: 10.1038/nrm.2017.87. Epub 2017 Sep 27.
5
Investigating the long-term legacy of statin therapy.
J Thorac Dis. 2017 Apr;9(4):936-939. doi: 10.21037/jtd.2017.03.10.
6
Myocardial infarction and future risk of cancer in the general population-the Tromsø Study.
Eur J Epidemiol. 2017 Mar;32(3):193-201. doi: 10.1007/s10654-017-0231-5. Epub 2017 Feb 7.
7
Statins are Associated With a Reduced Risk of Brain Cancer: A Population-Based Case-Control Study.
Medicine (Baltimore). 2016 Apr;95(17):e3392. doi: 10.1097/MD.0000000000003392.
8
Impact of cholesterol on disease progression.
Biomedicine (Taipei). 2015 Jun;5(2):7. doi: 10.7603/s40681-015-0007-8. Epub 2015 Jun 1.
9
Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.
Cancer Med. 2015 May;4(5):770-80. doi: 10.1002/cam4.411. Epub 2015 Mar 21.
10
Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer.
J Gastrointest Surg. 2011 Apr;15(4):551-7. doi: 10.1007/s11605-011-1448-3. Epub 2011 Feb 15.
本文引用的文献
1
The antitumour activities of statins.
Curr Oncol. 2007 Dec;14(6):246. doi: 10.3747/co.2007.159.
2
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51. doi: 10.1073/pnas.0706832104. Epub 2007 Nov 27.
3
Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer.
N Engl J Med. 2007 Oct 18;357(16):1640-8. doi: 10.1056/NEJMcpc079026.
4
Long-term follow-up of the West of Scotland Coronary Prevention Study.
N Engl J Med. 2007 Oct 11;357(15):1477-86. doi: 10.1056/NEJMoa065994.
5
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
Atherosclerosis. 2008 Apr;197(2):829-39. doi: 10.1016/j.atherosclerosis.2007.07.031. Epub 2007 Sep 10.
6
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
J Am Coll Cardiol. 2007 Jul 31;50(5):409-18. doi: 10.1016/j.jacc.2007.02.073. Epub 2007 Jul 16.
7
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease.
Ann Intern Med. 2007 Jul 3;147(1):1-9. doi: 10.7326/0003-4819-147-1-200707030-00002.
8
Regulatory T lymphocytes: pivotal components of the host antitumor response.
J Clin Oncol. 2007 Jun 20;25(18):2506-8. doi: 10.1200/JCO.2007.11.3191.
9
Tregs and rethinking cancer immunotherapy.
J Clin Invest. 2007 May;117(5):1167-74. doi: 10.1172/JCI31202.
10
Immunosenescence of ageing.
J Pathol. 2007 Jan;211(2):144-56. doi: 10.1002/path.2104.
Zotero 插件